World's Best Scientists 2026 revealed!
Stefano Colloca

Stefano Colloca

D-Index & Metrics

Immunology

D-Index
47
Citations
8842
World Ranking
4516
National Ranking
191

Stefano Colloca publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Stefano Colloca sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 112 publications — 5th percentile

5% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Stefano Colloca D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Stefano Colloca sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 47 D-Index — 9th percentile

9% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Stefano Colloca is affiliated with Reithera in Italy and has a research focus spanning multiple fields within medicine and molecular biology. Their work notably intersects immunology, infectious diseases, genetics, and oncology.

Their main fields of study include:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology
  • Immunology and Microbiology

Subfields of their research cover:

  • Infectious Diseases
  • Immunology
  • Molecular Biology
  • Genetics
  • Oncology

Main topics addressed in their research are:

  • SARS-CoV-2 and COVID-19 Research
  • Virus-based gene therapy research
  • Immunotherapy and Immune Responses
  • Vaccines and immunoinformatics approaches
  • CAR-T cell therapy research
  • Rabies epidemiology and control
  • Viral Infections and Outbreaks Research

Stefano Colloca has published extensively, with notable papers including:

  • "A Genetic Vaccine Encoding Shared Cancer Neoantigens to Treat Tumors with Microsatellite Instability," 2020, Cancer Research
  • "Immunogenicity of a new gorilla adenovirus vaccine candidate for COVID-19," 2021, Molecular Therapy
  • "MHC class II invariant chain-adjuvanted viral vectored vaccines enhances T cell responses in humans," 2020, Science Translational Medicine
  • "GRAd-COV2, a gorilla adenovirus-based candidate vaccine against COVID-19, is safe and immunogenic in younger and older adults," 2021, Science Translational Medicine
  • "A next generation vaccine against human rabies based on a single dose of a chimpanzee adenovirus vector serotype C," 2020, PLoS neglected tropical diseases

Frequent coauthors who have collaborated with Colloca include:

  • Stefania Capone
  • Antonella Folgori
  • Alessandra M. Contino
  • Alessandra Vitelli
  • Simone Battella

Their research has appeared regularly in several publication venues, with multiple contributions to:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • npj Vaccines
  • Science Translational Medicine
  • PLoS neglected tropical diseases
  • Vaccines

Best Publications

  • Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man

    Eleanor Barnes;Eleanor Barnes;Antonella Folgori;Stefania Capone;Leo Swadling

  • Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge

    Daphne A Stanley;Anna N Honko;Anna N Honko;Clement Asiedu;John C Trefry

  • A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees.

    Antonella Folgori;Stefania Capone;Lionello Ruggeri;Annalisa Meola

  • A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory.

    Leo Swadling;Stefania Capone;Richard D. Antrobus;Anthony Brown

  • Chimpanzee Adenovirus Vector Ebola Vaccine

    Julie E. Ledgerwood;Adam D. DeZure;Daphne A. Stanley;Emily E. Coates

  • Protective CD8 + T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation

    Katie J Ewer;Geraldine A O'Hara;Christopher J A Duncan;Katharine A Collins

  • Vaccine Vectors Derived from a Large Collection of Simian Adenoviruses Induce Potent Cellular Immunity Across Multiple Species

    Stefano Colloca;Eleanor Barnes;Antonella Folgori;Virginia Ammendola

  • A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA

    Katie Ewer;Tommy Rampling;Navin Venkatraman;Georgina Bowyer

  • ChAd63-MVA-vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humans

    Susanne H Sheehy;Christopher J A Duncan;Sean C Elias;Prateek Choudhary

  • Clinical Assessment of a Recombinant Simian Adenovirus ChAd63: A Potent New Vaccine Vector

    Geraldine A. O’Hara;Christopher J. A. Duncan;Katie J. Ewer;Katharine A. Collins

  • Prime-boost vectored malaria vaccines: progress and prospects.

    Adrian V S Hill;Arturo Reyes-Sandoval;Geraldine O'Hara;Katie Ewer

  • Vaccine-elicited human T cells recognizing conserved protein regions inhibit HIV-1

    Nicola Borthwick;Tina Ahmed;Beatrice Ondondo;Peter Hayes

  • Chimpanzee Adenovirus Vector Ebola Vaccine — Preliminary Report

    Julie E. Ledgerwood;Adam D. DeZure;Daphne A. Stanley;Laura Novik

  • Prime-Boost Immunization with Adenoviral and Modified Vaccinia Virus Ankara Vectors Enhances the Durability and Polyfunctionality of Protective Malaria CD8+ T-Cell Responses

    Arturo Reyes-Sandoval;Tamara Berthoud;Nicola Alder;Loredana Siani

  • Phase Ia Clinical Evaluation of the Plasmodium Falciparum Blood-Stage Antigen MSP1 in ChAd63 and MVA Vaccine Vectors

    Susanne H Sheehy;Christopher J A Duncan;Sean C Elias;Katharine A Collins

  • Phase Ia Clinical Evaluation of the Safety and Immunogenicity of the Plasmodium falciparum Blood-Stage Antigen AMA1 in ChAd63 and MVA Vaccine Vectors

    Susanne H. Sheehy;Christopher J. A. Duncan;Sean C. Elias;Sumi Biswas

  • Chimpanzee adenovirus vaccine carriers

    Agostino Cirillo;Stefano Colloca;Bruno Bruni Ercole;Annalisa Meola

  • Evaluation of the Efficacy of ChAd63-MVA Vectored Vaccines Expressing Circumsporozoite Protein and ME-TRAP Against Controlled Human Malaria Infection in Malaria-Naive Individuals

    Susanne H. Hodgson;Katie J. Ewer;Carly M. Bliss;Nick J. Edwards

  • A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: First-in-human trial of ChAd63-KH

    Mohamed Osman;Anoop Mistry;Ada Keding;Rhian Gabe

  • Chimpanzee adenovirus– and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults

    C A Green;E Scarselli;C J Sande;A J Thompson

Frequent Co-Authors

Alfredo Nicosia
Alfredo Nicosia University of Naples Federico II
Riccardo Cortese
Riccardo Cortese Schering-Plough
Antonella Folgori
Antonella Folgori University of Oxford
Adrian V. S. Hill
Adrian V. S. Hill University of Oxford
Sarah C. Gilbert
Sarah C. Gilbert University of Oxford
Paul Klenerman
Paul Klenerman University of Oxford
Katie J. Ewer
Katie J. Ewer University of Oxford
Simon J. Draper
Simon J. Draper University of Oxford
Gennaro Ciliberto
Gennaro Ciliberto Magna Graecia University
Ian D. Poulton
Ian D. Poulton University of Oxford

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology and healthcare, pursuing related online degrees offers flexible options to advance your career. Many professionals start with online nursing programs for non nurses, which provide foundational clinical knowledge and skills without requiring prior nursing experience.

If you're looking to accelerate your education, accelerated BSN programs for non nurses allow you to quickly earn a Bachelor of Science in Nursing. These programs are designed to transition non-nurses into nursing roles and open pathways into immunology-related practice areas.

For those seeking quicker entry into nursing, fastest and easiest LPN programs offer a practical route to working in healthcare settings. LPNs can gain valuable hands-on experience, which is beneficial for specialization later on.

Finally, advancing to higher clinical roles is possible through easiest nurse practitioner program options. Nurse practitioners often engage directly in immunology-related diagnostics and patient care, making these programs a strong career step for those passionate about immunology.

Best Scientists Citing Stefano Colloca

Trending Scientists

Recently Published Articles